Nanjing General Hospital

Nanjing, Jiangsu 210002

0 studies enrolling now · 2 studies all time

What they study most

Non-Small Cell Lung Cancer, Non-small Cell Lung Cancer

Studies at this site

• eXalt3: Study Comparing X-396 (Ensartinib) to Crizotinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients — Running, not enrolling
• Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC — Running, not enrolling